# Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Persons and Virologic Evaluation of the Modes of Influenza Virus Transmission Among Humans, Funding Opportunity Announcement (FOA) IP09-001 and IP09-003
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.
*Time and Date:* 8 a.m.-5 p.m., April 6, 2009 (Closed).
*Place:* Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337.
*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of “The Incidence and Etiology of Influenza-Associated Pneumonia in Hospitalized Persons and Virologic Evaluation of the Modes of Influenza Virus Transmission Among Humans, FOA IP09-001 and IP09-003.”
*Contact Person for More Information:* Gregory Anderson, M.S., M.P.H., Office of the Director, Coordinating Center for Infectious Diseases, CDC, 1600 Clifton Road, Mailstop E-60, Atlanta, GA 30333, *Telephone:* (404) 498-2275.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: March 13, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.